Objectives: This presentation examines the evolution of botulinum toxin type A (BTXA) injections, traditionally intramuscular for dynamic wrinkles. Modern approaches now incorporate intradermal techniques or a combination for more natural results. Through a comparative case study, we evaluate upper and lower eyelid position and tear trough morphology before and after treatment in subjects receiving either intramuscular or intradermal injections, offering insights into optimizing BTXA for periocular aesthetics.
Introduction: Botulinum toxin type A has traditionally been injected into facial muscles to reduce dynamic wrinkles, especially in the upper face. However, evolving techniques now include intradermal injections to achieve more natural and balanced results. This study explores these approaches through a comparative case review, analyzing not only upper facial aesthetic changes but also eyelid position and tear trough morphology, which are critical yet often overlooked indicators of successful periocular and upper face rejuvenation.
Materials / method: Two matched subjects were treated with botulinum toxin type A using different techniques. One received conventional intramuscular injections, while the other received a controlled intradermal application targeting the same regions. Comparatively, less dosing was used in the intradermal application case. Standardized photographs were taken at baseline and at week four. Aesthetic changes were assessed focusing specifically on eyelid height, lower eyelid support, and tear trough morphology.
Results: Both injection techniques effectively reduced dynamic wrinkles of the upper face. The intradermal method showed a clear advantage in enhancing eyelid position and softening tear trough contours without any added volume. These areas are often overlooked yet are essential for periocular harmony. Subject feedback favored the intradermal results for being more natural and comfortable. No complications or adverse events were observed, confirming the safety of both techniques in clinical application.
Conclusion: This case study supports the use of intradermal botulinum toxin injections as a valuable approach to upper face rejuvenation. While intramuscular techniques remain effective, intradermal application demonstrated superior refinement of eyelid position and tear trough shape. These areas are crucial yet underexamined markers of facial aging. Integrating intradermal techniques can enhance periocular outcomes and offer patients a more complete and natural aesthetic result without requiring additional procedures.
Disclosures
Did you receive any funding to support your research for this TOPIC?
No
Were you provided with any honoraria, payment or other compensation for your work on this study?
No
Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No
Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No
This work was not supported by any direct or non direct funding. It is under the author's own responsability
